Opportunities and challenges in the development of kinase inhibitor therapy for cancer

被引：147

作者：

Sawyers, CL ^{[1
]}

机构：

[1] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA

[2] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA

[3] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA

[4] Univ Calif Los Angeles, Dept Urol, Los Angeles, CA 90095 USA

[5] Univ Calif Los Angeles, Jonsson Canc Ctr, Los Angeles, CA 90095 USA

[6] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA

来源：

GENES & DEVELOPMENT | 2003年 / 17卷 / 24期

关键词：

D O I：

10.1101/gad.1152403

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

引用

页码：2998 / 3010

页数：13

共 101 条

[31] Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome. [J].

Druker, BJ ;

Sawyers, CL ;

Kantarjian, H ;

Resta, DJ ;

Reese, SF ;

Ford, JM ;

Capdeville, R ;

Talpaz, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1038-1042

[32] Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells [J].

Druker, BJ ;

Tamura, S ;

Buchdunger, E ;

Ohno, S ;

Segal, GM ;

Fanning, S ;

Zimmermann, J ;

Lydon, NB .

NATURE MEDICINE, 1996, 2 (05) :561-566

[33] Perspectives on the development of a molecularly targeted agent [J].

Druker, BJ .

CANCER CELL, 2002, 1 (01) :31-36

[34] Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J].

Druker, BJ ;

Talpaz, M ;

Resta, DJ ;

Peng, B ;

Buchdunger, E ;

Ford, JM ;

Lydon, NB ;

Kantarjian, H ;

Capdeville, R ;

Ohno-Jones, S ;

Sawyers, CL .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1031-1037

[35] Reversible tumorigenesis by MYC in hematopoietic lineages [J].

Felsher, DW ;

Bishop, JM .

MOLECULAR CELL, 1999, 4 (02) :199-207

[36]

FORAN J, 2002, P AM SOC HEMATOLOGY, P2196

[37]

FOTI A, 1991, BLOOD, V77, P2441

[38] Gene-targeting reveals physiological roles and complex regulation of the phosphoinositide 3-kinases [J].

Foukas, LC ;

Okkenhaug, K .

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2003, 414 (01) :13-18

[39]

Frederick L, 2000, CANCER RES, V60, P1383

[40] Phosphoinositide 3-kinase knockout mice:: role of p85α in B cell development and proliferation [J].

Fruman, DA ;

Snapper, SB ;

Yballe, CM ;

Alt, FW ;

Cantley, LC .

BIOCHEMICAL SOCIETY TRANSACTIONS, 1999, 27 (04) :624-629

← 1 2 3 4 5 6 7 8 9 10 →